Study details
Enrolling now
PUQS Sampling Study
Abramson Cancer Center at Penn Medicine
NCT IDNCT07199517ClinicalTrials.gov data as of Apr 2026
Target enrollment
472
Study length
about 4.6 years
Ages
21+
Locations
1 site in PA
About this study
Researchers are testing whether harm reduction products or medicinal nicotine are more effective at reducing cigarette smoking compared to a control group. The trial will follow participants for six months after they start using one of the treatments, and researchers will investigate why some people respond better than others.
Based on ClinicalTrials.gov records.
What participants do
- 1.HRP Sampling period
- 2.NPL Sampling period
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.